New Two-Drug attack on tough lung cancer
NCT ID NCT03527108
Summary
This study is testing whether combining two existing drugs, nivolumab and ramucirumab, can better control advanced lung cancer that has come back after prior treatment. It will enroll about 36 adults who have already tried at least one other therapy. The main goal is to see if this combination can stop the cancer from growing, shrink it, or make it disappear for a period of time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
NYU Langone
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.